The study reports that people are finding drugs like Ozempic and Wegovy helpful to manage cravings, not just for food, but ...

Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...

"Anti-vaccine rhetoric is a threat to global health," said biomedical scientist Andrea C. Love, PhD, emphasizing how ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

As we turn the page on the month of January, millions of Americans are working to keep up with their fitness-related new year’s resolutions. They’re going to the gym, dieting […] ...

Dr Pandey shares key insights on dosing, monitoring, and patient education to sustain therapy and improve outcomes. Essential for cardiologists and PCPs!

West Pharmaceutical Services Inc.'s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 ...

Hims & Hers Health (HIMS) stock hit a new all-time high on Thursday as retail investors have taken interest in the telehealth ...

In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

A direct-to-consumer telehealth company advertisement that aired during the Super Bowl failed to mention the side effects of the drugs.

Novo Nordisk ( NVO -2.98%) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, ...